RxDoctor Payments Data

Flora Agyei

Psychiatric/Mental Health · Milwaukee, WINPI 1336446806

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Alkermes, Inc. at 28.4% of the total. Among psychiatric/mental health clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,742in general payments, 2019–2025

Across 205 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • Lundbeck LLC$624
  • Teva Pharmaceuticals USA, Inc.$519
  • AbbVie$507
  • Otsuka America Pharmaceutical, Inc.$313
  • Vanda Pharmaceuticals Inc.$263
  • plus $455 from 8 others

What the payments were for

  • Food & beverage$3,742100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,742 in reported general payments places this provider in the 90th percentile of 384 psychiatric/mental health providers in Wisconsin.

See all psychiatric/mental health providers in Wisconsin

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine18$122,166
Invega SustennaPaliperidone Palmitate12$43,559
VraylarCariprazine Hcl21$28,045
Lurasidone Hcl21$5,955
Aripiprazole61$2,869
Olanzapine38$997
Mirtazapine72$955
Risperidone60$796
Oxcarbazepine13$705
Ziprasidone Hcl13$653
Trazodone Hcl116$533
Zolpidem Tartrate57$530
Quetiapine Fumarate24$450
Benztropine Mesylate34$344
Sertraline Hcl74$286

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$519$122,16618 claims
Johnson & JohnsonInvega Sustenna$105$43,55912 claims
AbbVieVraylar$507$28,04521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 384 psychiatric/mental health providers in Wisconsin.

Other psychiatric/mental health in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →